🛌Adult Nursing Care Unit 8 – Renal and Urinary Disorders

Renal and urinary disorders affect millions worldwide, impacting kidney function and overall health. This unit covers the structure and function of the kidneys, common disorders, diagnostic tests, and treatment options. Understanding these topics is crucial for providing effective care. Nurses play a vital role in managing renal and urinary disorders. From monitoring patients and administering medications to providing education and emotional support, nursing interventions are essential. This unit also explores complications, risk factors, and emerging therapies in the field of nephrology.

Kidney Basics: Structure and Function

  • Kidneys are bean-shaped organs located in the retroperitoneal space on either side of the spine
  • Composed of an outer cortex and inner medulla, which contain millions of nephrons, the functional units of the kidney
  • Nephrons consist of a glomerulus, proximal convoluted tubule, loop of Henle, distal convoluted tubule, and collecting duct
  • Glomerulus filters blood to create an ultrafiltrate, which is modified as it passes through the tubules and ducts
  • Kidneys regulate fluid and electrolyte balance, maintain acid-base homeostasis, and excrete waste products (urea, creatinine)
  • Produce hormones such as erythropoietin (stimulates red blood cell production) and renin (regulates blood pressure)
  • Convert vitamin D to its active form, calcitriol, which is essential for calcium absorption and bone health

Common Renal and Urinary Disorders

  • Acute kidney injury (AKI) is a sudden decline in kidney function, often due to decreased blood flow, nephrotoxic agents, or urinary obstruction
  • Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years, frequently caused by diabetes or hypertension
  • Glomerulonephritis is inflammation of the glomeruli, which can be caused by infections, autoimmune disorders, or systemic diseases (lupus)
  • Nephrotic syndrome is characterized by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia
  • Urinary tract infections (UTIs) occur when bacteria invade the urethra, bladder (cystitis), or kidneys (pyelonephritis)
  • Renal calculi (kidney stones) form from crystallized minerals in the urinary tract, causing pain, hematuria, and potential obstruction
  • Benign prostatic hyperplasia (BPH) is an enlargement of the prostate gland that can lead to urinary retention and increased risk of UTIs in older men

Symptoms and Diagnostic Tests

  • Common symptoms of renal and urinary disorders include changes in urine output, color, or consistency; flank pain; edema; and fatigue
  • Urinalysis examines urine for abnormalities such as blood, protein, glucose, or bacteria
  • Blood tests measure serum creatinine and blood urea nitrogen (BUN) to assess kidney function
  • Estimated glomerular filtration rate (eGFR) is calculated from serum creatinine, age, sex, and race to determine the stage of CKD
  • Imaging studies such as ultrasound, CT, or MRI can detect structural abnormalities, obstructions, or tumors
  • Kidney biopsy may be performed to diagnose specific disorders (glomerulonephritis) and guide treatment
  • Cystoscopy allows direct visualization of the bladder and urethra to identify inflammation, stones, or tumors

Treatment Options and Medications

  • Treatment depends on the specific disorder, severity, and underlying cause
  • AKI management focuses on identifying and addressing the underlying cause, providing supportive care, and preventing complications
  • CKD treatment aims to slow disease progression, manage comorbidities (diabetes, hypertension), and prepare for renal replacement therapy (dialysis, transplantation)
  • Medications for renal and urinary disorders include:
    • Diuretics (furosemide) to manage fluid overload and edema
    • ACE inhibitors or ARBs to control hypertension and proteinuria
    • Antibiotics to treat UTIs and prevent recurrent infections
    • Phosphate binders and calcimimetics to control mineral and bone disorders in CKD
  • Dialysis (hemodialysis or peritoneal dialysis) is used to replace kidney function in end-stage renal disease (ESRD)
  • Kidney transplantation is the preferred treatment for ESRD, offering improved quality of life and survival compared to dialysis

Nursing Care and Interventions

  • Monitor vital signs, fluid balance, and urine output to assess kidney function and detect complications
  • Administer medications as prescribed and educate patients on their proper use and potential side effects
  • Encourage adequate hydration and nutrition, tailoring diets to manage electrolyte imbalances or other dietary restrictions
  • Assist with dialysis treatments and monitor for complications (hypotension, electrolyte imbalances, infections)
  • Provide wound care and dressing changes for patients with dialysis access sites (fistulas, grafts, catheters)
  • Implement fall prevention strategies for patients with weakness, dizziness, or polypharmacy
  • Collaborate with the interdisciplinary team (nephrologists, dietitians, social workers) to provide comprehensive care
  • Offer emotional support and resources for patients and families coping with chronic illness or ESRD

Complications and Risk Factors

  • Cardiovascular disease is the leading cause of death in patients with CKD or ESRD due to shared risk factors and the effects of kidney dysfunction on the cardiovascular system
  • Anemia is common in CKD due to decreased erythropoietin production and other factors (inflammation, iron deficiency)
  • Mineral and bone disorders (renal osteodystrophy) occur when the kidneys fail to regulate calcium, phosphorus, and vitamin D metabolism
  • Hyperkalemia can result from decreased potassium excretion in kidney disease and can lead to life-threatening arrhythmias
  • Malnutrition and protein-energy wasting are prevalent in CKD and ESRD due to dietary restrictions, inflammation, and other metabolic factors
  • Infections, particularly UTIs and bloodstream infections related to dialysis access, are more common and severe in patients with kidney disease
  • Polycystic kidney disease is an inherited disorder characterized by the growth of numerous cysts in the kidneys, leading to progressive kidney failure

Patient Education and Self-Care

  • Teach patients about their specific kidney or urinary disorder, its causes, and potential complications
  • Emphasize the importance of adhering to prescribed medications, dietary restrictions, and treatment regimens
  • Encourage lifestyle modifications (smoking cessation, exercise, stress management) to slow disease progression and improve overall health
  • Instruct patients on proper hygiene practices to prevent UTIs, such as wiping front to back and avoiding prolonged use of irritating products
  • Educate patients on the signs and symptoms of complications (fluid overload, infections) and when to seek medical attention
  • Provide resources for support groups, financial assistance, and community services to help patients cope with the challenges of living with kidney disease
  • Discuss advance care planning and treatment options (conservative management, dialysis, transplantation) as the disease progresses
  • Empower patients to actively participate in their care and decision-making, fostering a sense of control and self-efficacy

Emerging Therapies and Research

  • Stem cell therapy is being investigated as a potential treatment for AKI and CKD, aiming to regenerate damaged kidney tissue
  • Gene therapy targets specific genetic mutations responsible for inherited kidney disorders (polycystic kidney disease)
  • Bioartificial kidneys combine living kidney cells with artificial materials to create a wearable or implantable device that mimics kidney function
  • Xenotransplantation, or the transplantation of organs from animals (pigs) to humans, is being researched as a solution to the shortage of donor kidneys
  • Personalized medicine approaches use genetic and molecular profiling to tailor treatments to individual patients
  • Wearable and implantable sensors are being developed to continuously monitor kidney function and detect early signs of deterioration
  • Research on the gut-kidney axis explores the role of the microbiome in the development and progression of kidney disease
  • Clinical trials are ongoing to test new medications, such as SGLT2 inhibitors and mineralocorticoid receptor antagonists, for their potential to slow CKD progression and improve cardiovascular outcomes


© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.

© 2024 Fiveable Inc. All rights reserved.
AP® and SAT® are trademarks registered by the College Board, which is not affiliated with, and does not endorse this website.